M. Volkova

Cardiology and Cardiovascular Medicine · 2011

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Volkova trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Stockman
  2. S. Swain

Papers from M. Volkova's perspective

Ordered by how strongly the researchers M. Volkova trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Congestive heart failure in patients treated with doxorubicin (Cancer)
  2. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
  3. Protective effects of carvedilol against anthracycline-induced cardiomyopathy. (Journal of the American College of Cardiology)
  4. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. (Journal of the American College of Cardiology)
  5. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort
  6. Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy (Circulation)
  7. Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity (Pharmacological Reviews)
  8. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European… (European Heart Journal)
  9. Cardiac dysfunction in the trastuzumab clinical trials experience. (Journal of Clinical Oncology)
  10. Anthracycline-induced cardiotoxicity. (Acta medica)

Their papers